Bacterial vaginosis (BV) is the most commonly reported microbiological syndrome among
women of childbearing age. BV is characterized by a shift in the vaginal flora from the …

The application of next generation sequencing techniques has allowed the characterization
of the urinary tract microbiome and has led to the rejection of the pre-established concept of …

Bacterial DNA and live bacteria have been detected in human urine in the absence of
clinical infection, challenging the prevailing dogma that urine is normally sterile. Urgency …

Lactic acid and short chain fatty acids (SCFAs) produced by vaginal microbiota have
reported antimicrobial and immune modulatory activities indicating their potential as …

We conducted a systematic review of the Medline database (US National Library of
Medicine, National Institutes of Health, Bethesda, MD, USA) to determine if consistent …

Communities of microbiota have been associated with numerous health outcomes, and
while much emphasis has been placed on the gastrointestinal niche, there is growing …

Elucidating the cause of bacterial vaginosis has important implications for diagnosis and
treatment. Our current bacterial vaginosis pathogenesis model provides a framework for key …

The vaginal microbiota refers to the microorganisms that reside in the vagina. These
microorganisms contribute significantly to a woman's reproductive and general health. A …

Whole genome sequence analysis (digital DNA–DNA hybridization and average nucleotide
identity) was carried out for 81 sequenced full genomes of the genus Gardnerella, including …

Bacterial vaginosis (BV) is the worldwide leading vaginal disorder among women of
reproductive age. BV is characterized by the replacement of beneficial lactobacilli and the …